Ascend Wellness Holdings (AAWH) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Ascend Wellness Holdings (AAWH) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.75% |
| Mar 31, 2026 | 39.44% |
| Dec 31, 2025 | -88.59% |
| Sep 30, 2025 | -5.81% |
| Jun 30, 2025 | -26.74% |
| Mar 31, 2025 | -14.69% |
| Dec 31, 2024 | 40.58% |
| Sep 30, 2024 | -29.71% |
| Jun 30, 2024 | -19.94% |
| Mar 31, 2024 | 6.10% |
| Dec 31, 2023 | -72.09% |
| Sep 30, 2023 | -1,436.50% |
| Jun 30, 2023 | 104.55% |
| Mar 31, 2023 | -22.74% |
| Dec 31, 2022 | 10.75% |
| Sep 30, 2022 | 20.36% |
| Jun 30, 2022 | 23.88% |
| Mar 31, 2022 | -68.46% |
| Dec 31, 2021 | -26.75% |
| Sep 30, 2021 | 70.99% |